Paratek Pharmaceuticals Inc (PRTK) Return on Investment ROI from the first quarter of 2023 to first quarter of 2022 and for the year 2023, average high and low, overall ranking from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Paratek Pharmaceuticals Inc   (NASDAQ: PRTK)


Paratek Pharmaceuticals Inc's ROI from its first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Paratek Pharmaceuticals Inc's ROI in the first quarter of 2023?
Paratek Pharmaceuticals Inc recorded a cumulative net loss of $-66 million during 12 months ending in the first quarter of 2023, resulting in a negative return on investment (ROI) of -52.19%.

Within the Healthcare sector 653 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the fourth quarter of 2022 from 4165 to 4527.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Investment Change TTM -15.98 % -11.49 % -8.8 % -6.72 % -7.98 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 118 135 118 133 140
Return On Investment (TTM) -52.19 % -48.29 % -65.36 % -59.7 % -39.08 %
PRTK's Overall Ranking # 4527 # 4165 # 0 # 0 # 0
Seq. Investment Change TTM -4.21 % -2.97 % -5.81 % -4.03 % 0.9 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -66 -64 -89 -86 -59

PRTK Company Profile >> Back to PRTK Roi Comparisons >> See Annual PRTK Return On Investment



Return On Investment PRTK's Ranking
Within: No.
Industry # 286
Sector # 654
Overall # 4527

Return On Investment Statistics
High Average Low
17.77 %
-53.18 %
-98.44 %
(Sep. 30, 2015)   (Dec 31 2016)







Financial Statements
Paratek Pharmaceuticals Inc's I. Quarter Investments $ 118 Millions PRTK's Balance sheet
Paratek Pharmaceuticals Inc's I. Quarter Income $ -20 Millions Quarterly PRTK's Income Statement
PRTK's Income by Division See PRTK's Income by Division


PRTK Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions 135 151 151 225 282
Y / Y Investment Growth -10.65 % -0.06 % -32.67 % -20.43 % 92.28 %
Net Income in Millions -64 -59 -97 -129 -112
Y / Y Net Income Growth - - - - -
Annual Return On Investment -47.03 % -39.06 % -63.78 % -57.3 % -39.77 %


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
PRTK's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for PRTK's Competitors
Subscribers only: Roi for Paratek Pharmaceuticals Inc's Suppliers
Subscribers only: Return On Investment for PRTK's Customers

Other Ratios
PRTK's Roa PRTK's Inventory Turnover Ratio PRTK's Growth Rates PRTK's Dividend Statistics
PRTK's Profitability Ratios PRTK's Asset Turnover Ratio PRTK's Dividend Growth
PRTK's Roe PRTK's Valuation Ratios PRTK's Financial Strength Ratios PRTK's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2023, within Healthcare Sector ROI

Date modified: 2026-09-26T07:07:25+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.